Multiple sclerosis: open trials in Croatia

9 open trials have a site in Croatia. Registry data; only the trial team decides who can take part.

NCT07067463
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
Trial Treatment · Phase 3 · Zenas BioPharma (USA), LLC
University Hospital Centre Zagreb, Zagreb
Registry updated 2026-11-03
2023-504358-36-00
Efficacy and safety study of frexalimab (SAR441344) in adults with relapsing forms of multiple sclerosis
Trial Treatment · Phase 3 · Sanofi-Aventis Recherche & Developpement
University Hospital Centre Zagreb, Zagreb
Registry updated 2026-10-28
NCT07299019
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
Trial Treatment · Phase 3 · Zenas BioPharma (USA), LLC
University Hospital Centre Zagreb, Zagreb
Registry updated 2026-10-27
2024-512914-16-00
A Randomized, Double-blind, Study to Demonstrate Pharmacokinetic Similarity, and Evaluate Safety, Immunogenicity, Pharmacodynamics and Clinical Effects between ABP 692 and Ocrevus® (Ocrelizumab) in Subjects with Relapsing-remitting Multiple Sclerosis
Trial Treatment · Phase 3 · Amgen Inc.
Klinicki bolnicki centar Sestre milosrdnice, Grad Zagreb
Registry updated 2026-10-20
NCT07225504
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
Trial Treatment · Phase 3 · Novartis Pharmaceuticals
Novartis Investigative Site, Varaždin · Novartis Investigative Site, Zagreb
Registry updated 2026-10-13
2024-511686-11-00
Efficacy and safety of ofatumumab and siponimod compared to fingolimod in pediatric patients with multiple sclerosis
Trial Treatment · Phase 3 · Novartis Pharma AG
Children's Hospital Zagreb, Zagreb
Registry updated 2026-09-29
2024-512707-40-00
A Phase 2 Study of Obexelimab in Patients with Relapsing Multiple Sclerosis
Trial Treatment · Phase 2 · Zenas Biopharma (USA) LLC
University Hospital Centre Zagreb, Zagreb
Registry updated 2026-08-27
2025-521546-23-00
A clinical trial to find out how well LOU064 (remibrutinib) works and how safe it is for people with secondary progressive multiple sclerosis
Trial Treatment · Phase 3 · Novartis Pharma AG
Klinicki bolnicki centar Sestre milosrdnice, Grad Zagreb · KBC Zagreb, Grad Zagreb · Poliklinika Solmed d.o.o., Grad Zagreb · Klinički bolnički centar Osijek, Osijek · Clinical Hospital Centre Rijeka, Rijeka · Opca Bolnica Varazdin, Varazdin · University Hospital Sveti Duh, Zagreb
Registry updated 2026-07-30
NCT04604041
Investigation of Subclinical Markers of Multiple Sclerosis
Research · University of Split, School of Medicine
University of Split School of Medicine, Split
Registry updated 2023-10-02

All Multiple sclerosis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error